Luan Lima

Mrs. Luan Lima

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2020 in Human & Experimental Toxicology
Verified
Journal Article
Closed access
PDF file
DFDp Franco
Dp Franco
BBBi de Biazi
Bi de Biazi
TZTa Zanetti
Ta Zanetti
LMLA Marques
LA Marques
LLLuan Lima
Luan Lima
MMM S Mantovani
M S Mantovani
This study aimed to evaluate the modes of action of harringtonine (HT) and homoharringtonine (HHT) alkaloids in cell with wild (HepG2/C3A) and mutant p53 (HuH-7.5). We performed assays for cytotoxicity, genotoxicity, induction of apoptosis, cell cycle phase, and membrane integrity. Obtained data were compared with the relative expression of mRNA of genes related to proliferation, apoptosis, cell cycle control, metabolism of xenobiotics, and reticulum endoplasmic stress. The relative expression of the genes showed an increase in apoptosis-inducing mRNAs, such as TNF and BBC3, as well as a reduction in BCL2 and BAK. The mRNAs of CYP2E1 and CYP2C19 xenobiotic metabolism genes increased in both lineages, while CYP3A4 increased only in the HuH-7.5 lineage. The mRNA expression of endoplasmic reticulum (ER) stress genes (ERN1 and EIF2AK3) was shown to increase in HHT and HT treatments. A similar increase was recorded in the mRNA expression of the TRAF2 gene. The changes observed in this study support the hypothesis that ER stress was more strongly associated with TNF induction, causing cell death by apoptosis in p53 mutant cells. This result with wild and mutant p53 cells may have clinical implications in the use of these compounds.

11 August 2022 in Journal of Toxicology and Environmental Health, Part A
Verified
Journal Article
Closed access
LLLuan Lima
Luan Lima
MSMatheus Felipe da Silva
Matheus Felipe da Silva
VCVirginia Marcia Concato
Virginia Marcia Concato
DRDébora Berbel Lirio Rondina
Débora Berbel Lirio Rondina
TZThalita Alves Zanetti
Thalita Alves Zanetti
MMMário Sérgio Mantovani
Mário Sérgio Mantovani
Fluopsin C is an antibiotic compound derived from secondary metabolism of different microorganisms, which possesses antitumor, antibacterial, and antifungal activity. Related to fluopsin C antiproliferative activity, the aim of this study was to examine the following parameters: cytotoxicity, genotoxicity, cell cycle arrest, cell death induction (apoptosis), mitochondrial membrane potential (MMP), colony formation, and mRNA expression of genes involved in adaptive stress responses and cellular death utilizing a monolayer. In addition, a three-dimensional cell culture was used to evaluate the effects on growth of tumor spheroids. Fluopsin C was cytotoxic (1) producing cell division arrest in the G1 phase, (2) elevating expression of mRNA of the CDKN1A gene and (3) decrease in expression of mRNA H2AFX gene. Further, fluopsin C enhanced DNA damage as evidenced by increased expression of mRNA of GADD45A and GPX1 genes, indicating that reactive oxygen species (ROS) may be involved in the observed genotoxic response. Reticulum stress was also detected as noted from activation of the ribonuclease inositol-requiring protein 1 (IRE1) pathway, since a rise in mRNA expression of the ERN1 and TRAF2 genes was observed. During the cell death process, an increase in mRNA expression of the BBC3 gene was noted, indicating participation of this antibiotic in oncotic (ischemic) cell death. Data thus demonstrated for the first time that fluopsin C interferes with the volume of tumor spheroids, in order to attenuate their growth. Our findings show that fluopsin C modulates essential molecular processes in response to stress and cell death.

6 September 2023 in Journal of Toxicology and Environmental Health, Part A
Verified
Journal Article
Closed access
LOLiana Martins de Oliveira
Liana Martins de Oliveira
LLLuan Lima
Luan Lima
MSMatheus Felipe da Silva
Matheus Felipe da Silva
IFIngrid Felicidade
Ingrid Felicidade
SLSandra Regina Lepri
Sandra Regina Lepri
MMMário Sérgio Mantovani
Mário Sérgio Mantovani
Curcumin is an antiproliferative phytochemical extracted from Curcuma longa L and which has been studied in preclinical drug screening using cell monolayers and animal models. However, several limitations of these culture systems may be overcome by performing screening with three-dimensional (3-D) cell culture. The aim of this study was to investigate the effects of curcumin on cytotoxicity and genotoxicity as well as spheroid growth using cervical adenocarcinoma HeLa cell spheroids by performing RT-PCR mRNA expression of genes involved in cell death (CASP3, CASP8, CASP9, PARP1, BBC3, BIRC5, BCL2, TNF), autophagy (BECN1, SQSTM1), cell cycle regulation (TP53, C-MYC, NF-kB, CDKN1A, m-TOR, TRAF-2), DNA damage repair (H2AFX, GADD45A, GADD45G), oxidative stress (GPX1), reticulum stress (EIF2AK3, ERN1), and invasion (MMP1, MMP9) was investigated. Curcumin was cytotoxic in a concentration-dependent manner. Curcumin-treated spheroids exhibited lower proliferative recovery and cell proliferation attenuation, as observed in the clonogenic assay. Further, no marked genotoxicity was detected. Curcumin-treated spheroids displayed reduced expression of BECN1 (2.9×), CASP9 (2.1×), and PARP1 (2.1×) mRNA. PARP1 inhibition suggested disruption of essential pathways of proliferation maintenance. Downregulated expression of CASP9 mRNA and unchanged expression of CASP3/8 mRNA suggested caspase-independent cell death, whereas downregulated expression of BECN1 mRNA indicated autophagic disruption. Therefore, curcumin exhibits the potential for drug development with antiproliferative activity to be considered for use in cancers.

16 September 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
ASAndresa Hiromi Sakai
Andresa Hiromi Sakai
ÉPÉrica Romão Pereira
Érica Romão Pereira
ASAnna Gabriele Prado dos Santos
Anna Gabriele Prado dos Santos
DQDébora Hipólito Quadreli
Débora Hipólito Quadreli
LLLuan Lima
Luan Lima
Juliana Mara SerpeloniJuliana Mara Serpeloni
Juliana Mara Serpeloni
Background/Objectives: Urothelial bladder carcinoma (UBC) is one of the most prevalent malignancies worldwide, and efforts have intensified to identify molecular markers that improve the prognosis and reduce treatment costs. Among the regulators of tumor behavior, microRNAs (miRNAs) have emerged as promising biomarkers for cancer diagnoses and treatment. The modulation of miR-25-3p has been associated with pancreatic, colorectal, and lung cancers; its role in UBC remains poorly explored. In this study, we investigated the effects of miR-25-3p modulation in a high-grade and muscle-invasive bladder cancer (MIBC) cell line (T24), using in vitro functional assays and bioinformatics approaches. Results: Bioinformatics analyses using TCGA-BLCA datasets revealed that miR-25-3p is upregulated in tumor tissues compared to non-tumor tissues, prompting an investigation into its molecular targets and related pathways. The transfection of T24 cells with an miR-25-3p mimic and inhibitor led to respective overexpression (11.16-fold) and downregulation (-2.82-fold) compared to the negative control. Functionally, miR-25-3p overexpression increased cell proliferation, viability, and migration, while its inhibition decreased the cell migration capacity. A gene expression analysis revealed that miR-25-3p overexpression resulted in the downregulation of TP53, AIFM1, NFE2L2, TFRC, ACSL4, SLC7A11, and SLC3A2, whereas MMP9, MMP11, and GPX4 were upregulated, suggesting a role in both migration and ferroptosis regulation. In the inhibitor group, increased SLC3A2 and decreased MMP11 expression further supported this connection. Our results using an in vitro model for MIBC with the transfection of T24 cells suggest that miR-25-3p influences key pathways involved in oxidative stress and cell death, promoting a more aggressive tumor phenotype. Conclusions: The modulation of miR-25-3p impacts the behavior of T24 bladder cancer cells and may indicate its role in disease progression. Our results underscore the potential of miR-25-3p as a prognostic biomarker and support further studies considering its therapeutic relevance in managing high-grade and muscle-invasive bladder cancer.

27 February 2026 in Archives of Toxicology
Verified
Journal Article
Open access
PDF file
LLLuan Lima
Luan Lima
MSMatheus Felipe da Silva
Matheus Felipe da Silva
LOLiana Martins de Oliveira
Liana Martins de Oliveira
MAMaria Claudia Terkelli de Assis
Maria Claudia Terkelli de Assis
ICIsabella Cristina Oliveira Carvalho
Isabella Cristina Oliveira Carvalho
MMMário Sérgio Mantovani
Mário Sérgio Mantovani
Copper-based metallodrugs are promising anticancer agents, but their toxicity limits clinical translation. This study evaluated the toxicological and molecular effects of PEGylated Fluopsin C (PEG-FlpC) in in vitro human non-small-cell lung carcinoma (NCI-H460) cells cultured as 2D monolayer and 3D spheroids. Cells were exposed to PEG-FlpC at its IC 50 (1.0 µM) for 24 h. Flow cytometry revealed G₁-phase arrest and non-apoptotic cell death. PEG-FlpC markedly suppressed spheroid growth, with 2 × IC 50 -treated spheroids growing only 58.1% compared to 131.6% in the control. Ultrastructural analyses showed mitochondrial clustering and swelling, ER dilation, and cytoplasmic vacuolization. Gene profiling demonstrated downregulation of TP53 and BECN1 , with upregulation of TP73 and SQSTM1 , consistent with autophagy blockade and stress activation. PEG-FlpC modulated ferroptosis-related ( GPX4 , SLC7A11 , and TFRC ) and cuproptosis-related ( ATP7B , MTF1 , DLAT , and CDKN2A ) genes. Pharmacological inhibition confirmed a predominantly copper-mediated mechanism, as TTM (10 µM) restored 77.7% of metabolic activity. Combined inhibition with TTM and Fer-1 (1 µM) further increased viability to 89.4%, indicating that PEG-FlpC induces non-apoptotic regulated cell death through an interconnected cuproptosis–ferroptosis mechanism associated with mitochondrial dysfunction.

3 November 2026 in Journal of Applied Toxicology
Verified
Journal Article
Open access
PDF file
ARAgda Lorena Corrêa Rocha
Agda Lorena Corrêa Rocha
CWCaroline Fernandes Westin
Caroline Fernandes Westin
ENErika Tyemi Goya Niekawa
Erika Tyemi Goya Niekawa
GAGaldino Andrade
Galdino Andrade
LLLuan Lima
Luan Lima
MMMário Sérgio Mantovani
Mário Sérgio Mantovani
Indolinones are compounds with recognized antineoplastic properties and can act as inhibitors of multiple kinases. However, the antitumor effects of 2‐carboxy‐2‐heptano‐indolin‐3‐one (IDC) have not yet been investigated in cervical cancer models. This study investigated the cytotoxic and pro‐apoptotic effects of IDC in HeLa cells, with emphasis on a three‐dimensional spheroid model, and evaluated its effects on spheroid growth, cell cycle distribution, apoptosis, and the expression of genes associated with cell death and DNA damage responses. Cell viability was assessed in monolayer cultures using the resazurin assay, while spheroid growth and morphology were evaluated by microscopy and volumetric analysis. Apoptosis and cell cycle distribution were investigated by flow cytometry, and gene expression was assessed by RT‐qPCR. IDC reduced cell viability by up to 80% in monolayer cultures and significantly inhibited spheroid growth, with loss of structural integrity and absence of recovery after treatment withdrawal. Flow cytometry revealed 81.7–83.6% apoptotic cells following IDC treatment, compared with 35.8% in the vehicle control. No significant changes in G1, S, or G2/M cell cycle distribution were observed. RT‐qPCR showed increased mRNA levels of CASP8 , CASP9 , CASP3 , BBC3 , and GADD45A and decreased levels of TP53 , CDKN1A , and MYC . These transcriptional changes suggest the involvement of apoptotic signaling and DNA damage response mechanisms. Overall, IDC exhibited cytotoxic and pro‐apoptotic effects in HeLa cells and impaired three‐dimensional spheroid growth and integrity, supporting further investigation of its antineoplastic potential in cervical cancer.